Annual EBITDA
-$684.30 M
-$1.52 B-181.48%
December 31, 2023
Summary
- As of February 25, 2025, VIR annual EBITDA is -$684.30 million, with the most recent change of -$1.52 billion (-181.48%) on December 31, 2023.
- During the last 3 years, VIR annual EBITDA has fallen by -$392.77 million (-134.72%).
- VIR annual EBITDA is now -181.48% below its all-time high of $839.85 million, reached on December 31, 2022.
Performance
VIR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$215.70 M
-$87.60 M-68.39%
September 30, 2024
Summary
- As of February 25, 2025, VIR quarterly EBITDA is -$215.70 million, with the most recent change of -$87.60 million (-68.39%) on September 30, 2024.
- Over the past year, VIR quarterly EBITDA has stayed the same.
- VIR quarterly EBITDA is now -121.24% below its all-time high of $1.02 billion, reached on March 31, 2022.
Performance
VIR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$562.63 M
-$36.92 M-7.02%
September 30, 2024
Summary
- As of February 25, 2025, VIR TTM EBITDA is -$562.63 million, with the most recent change of -$36.92 million (-7.02%) on September 30, 2024.
- Over the past year, VIR TTM EBITDA has stayed the same.
- VIR TTM EBITDA is now -135.18% below its all-time high of $1.60 billion, reached on March 31, 2022.
Performance
VIR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VIR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -181.5% | 0.0% | 0.0% |
| 3 y3 years | -134.7% | -56.6% | -79.6% |
| 5 y5 years | -490.2% | -56.6% | -79.6% |
VIR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -181.5% | at low | -121.2% | +3.5% | -135.2% | +16.0% |
| 5 y | 5-year | -181.5% | at low | -121.2% | +3.5% | -135.2% | +16.0% |
| alltime | all time | -181.5% | at low | -121.2% | +3.5% | -135.2% | +16.0% |
Vir Biotechnology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$215.70 M(+68.4%) | -$562.63 M(+7.0%) |
| Jun 2024 | - | -$128.09 M(+69.5%) | -$525.71 M(-12.8%) |
| Mar 2024 | - | -$75.56 M(-47.3%) | -$602.68 M(-9.4%) |
| Dec 2023 | -$684.30 M(-181.5%) | -$143.28 M(-19.9%) | -$664.85 M(-0.8%) |
| Sep 2023 | - | -$178.77 M(-12.8%) | -$670.13 M(+127.4%) |
| Jun 2023 | - | -$205.07 M(+48.9%) | -$294.71 M(-5.9%) |
| Mar 2023 | - | -$137.73 M(-7.3%) | -$313.26 M(-137.3%) |
| Dec 2022 | $839.85 M(+96.9%) | -$148.55 M(-175.5%) | $839.85 M(-46.2%) |
| Sep 2022 | - | $196.65 M(-187.9%) | $1.56 B(+18.9%) |
| Jun 2022 | - | -$223.63 M(-122.0%) | $1.31 B(-17.9%) |
| Mar 2022 | - | $1.02 B(+77.1%) | $1.60 B(+274.9%) |
| Dec 2021 | $426.56 M | $573.27 M(-1204.6%) | $426.56 M(-268.1%) |
| Sep 2021 | - | -$51.90 M(-183.1%) | -$253.78 M(-11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $62.42 M(-139.7%) | -$288.06 M(-23.8%) |
| Mar 2021 | - | -$157.23 M(+46.9%) | -$378.17 M(+29.7%) |
| Dec 2020 | -$291.54 M(+68.1%) | -$107.06 M(+24.2%) | -$291.54 M(+18.0%) |
| Sep 2020 | - | -$86.19 M(+211.3%) | -$247.07 M(+19.2%) |
| Jun 2020 | - | -$27.68 M(-60.8%) | -$207.35 M(-3.2%) |
| Mar 2020 | - | -$70.60 M(+12.8%) | -$214.31 M(+23.5%) |
| Dec 2019 | -$173.46 M(+49.6%) | -$62.59 M(+34.7%) | -$173.46 M(+26.8%) |
| Sep 2019 | - | -$46.47 M(+34.2%) | -$136.76 M(+10.4%) |
| Jun 2019 | - | -$34.64 M(+16.4%) | -$123.90 M(+38.8%) |
| Mar 2019 | - | -$29.76 M(+14.9%) | -$89.26 M(+50.0%) |
| Dec 2018 | -$115.94 M(+43.0%) | -$25.90 M(-22.9%) | -$59.50 M(+77.1%) |
| Sep 2018 | - | -$33.60 M | -$33.60 M |
| Dec 2017 | -$81.06 M | - | - |
FAQ
- What is Vir Biotechnology annual EBITDA?
- What is the all time high annual EBITDA for Vir Biotechnology?
- What is Vir Biotechnology annual EBITDA year-on-year change?
- What is Vir Biotechnology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vir Biotechnology?
- What is Vir Biotechnology quarterly EBITDA year-on-year change?
- What is Vir Biotechnology TTM EBITDA?
- What is the all time high TTM EBITDA for Vir Biotechnology?
- What is Vir Biotechnology TTM EBITDA year-on-year change?
What is Vir Biotechnology annual EBITDA?
The current annual EBITDA of VIR is -$684.30 M
What is the all time high annual EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high annual EBITDA is $839.85 M
What is Vir Biotechnology annual EBITDA year-on-year change?
Over the past year, VIR annual EBITDA has changed by -$1.52 B (-181.48%)
What is Vir Biotechnology quarterly EBITDA?
The current quarterly EBITDA of VIR is -$215.70 M
What is the all time high quarterly EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high quarterly EBITDA is $1.02 B
What is Vir Biotechnology quarterly EBITDA year-on-year change?
Over the past year, VIR quarterly EBITDA has changed by $0.00 (0.00%)
What is Vir Biotechnology TTM EBITDA?
The current TTM EBITDA of VIR is -$562.63 M
What is the all time high TTM EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high TTM EBITDA is $1.60 B
What is Vir Biotechnology TTM EBITDA year-on-year change?
Over the past year, VIR TTM EBITDA has changed by $0.00 (0.00%)